Reuters: Carlyle near deal to buy J&J's clinical diagnostics unit

|About: The Carlyle Group (CG)|By:, SA News Editor

Carlyle Group (CG) appears to be the leader to acquire Johnson & Johnson's (JNJ) clinical diagnostics unit, beating out P-E peer Blackstone (BX) and its partner Danaher (DHR), Reuters reports.

The exact price of CG's offer is not known, but a deal likely would fetch ~$4B and could be completed within the next two weeks.

JNJ's ortho clinical diagnostics unit makes blood-screening equipment and laboratory blood tests; it's a small player in a market led by Roche (RHHBY, RHHBF), Siemens (SI), Abbott Labs (ABT) and DHR.